SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis), which is often incurable. Researchers say this study moves them closer to clinical trials for RK-33.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma Scientists Identify Potential New Immune System Target to Head Off the Spread of Breast Cancer Cells Johns Hopkins Researchers Identify Key Markers in Pancreatic Cancer Progression Using a New Analysis Pipeline Audio: Federal breast density notification law
    Johns Hopkins

    2024 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top